BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35484165)

  • 1. MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by regulating WNT5A/β-catenin signaling.
    Chung YH; Cheng YT; Kao YH; Tsai WC; Huang GK; Chen YT; Shen YC; Tai MH; Chiang PH
    Sci Rep; 2022 Apr; 12(1):6955. PubMed ID: 35484165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells.
    Chung YH; Li SC; Kao YH; Luo HL; Cheng YT; Lin PR; Tai MH; Chiang PH
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28829370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-26a-5p Targets WNT5A to Protect Cardiomyocytes from Injury Due to Hypoxia/Reoxygenation Through the Wnt/β-catenin Signaling Pathway.
    Yan G; Wang J; Fang Z; Yan S; Zhang Y
    Int Heart J; 2021 Sep; 62(5):1145-1152. PubMed ID: 34544974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-145-5p suppresses cell proliferation, migration, and invasion in upper tract urothelial carcinoma by targeting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase.
    Luo HL; Lee YC; Chang YL; Hsu WC; Wu YT; Jhan JH; Lin HH; Wu YR; Ke HL; Liu HY
    J Cell Biochem; 2023 Sep; 124(9):1324-1345. PubMed ID: 37475541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of miR-26a-5p/Wnt5a signaling in gambogic acid-induced inhibition of gastric cancer.
    Zhang Z; Liang L; Cao G
    J Biochem Mol Toxicol; 2021 Apr; 35(4):e22721. PubMed ID: 33533530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human PMSCs-derived small extracellular vesicles alleviate neuropathic pain through miR-26a-5p/Wnt5a in SNI mice model.
    Lu Y; Zhang J; Zeng F; Wang P; Guo X; Wang H; Qin Z; Tao T
    J Neuroinflammation; 2022 Sep; 19(1):221. PubMed ID: 36071475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-145 suppresses cell migration and invasion in upper tract urothelial carcinoma by targeting ARF6.
    Hsu WC; Li WM; Lee YC; Huang AM; Chang LL; Lin HH; Wu WJ; Li CC; Liang PI; Ke HL
    FASEB J; 2020 Apr; 34(4):5975-5992. PubMed ID: 32077148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA KCNQ1OT1 knockdown inhibits viability, migration and epithelial-mesenchymal transition in human lens epithelial cells via miR-26a-5p/ITGAV/TGF-beta/Smad3 axis.
    Liu J; Dong Y; Wen Y; Shi L; Zhu Z; Ke G; Gu Y
    Exp Eye Res; 2020 Nov; 200():108251. PubMed ID: 32950535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MicroRNA-26a-5p targets Wnt5a to regulate osteogenic differentiation of human periodontal ligament stem cell from inflammatory microenvironment].
    Zhang KK; Geng YD; Wang SB; Huo L
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Oct; 54(10):662-669. PubMed ID: 31607001
    [No Abstract]   [Full Text] [Related]  

  • 10. MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma.
    Shi D; Wang H; Ding M; Yang M; Li C; Yang W; Chen L
    Onco Targets Ther; 2019; 12():6605-6616. PubMed ID: 31496749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircVAPA exerts oncogenic property in non-small cell lung cancer by the miR-876-5p/WNT5A axis.
    Zhao Y; Dai Q; Fu X; Chen Q; Tang Y; Gao X; Zhou Q
    J Gene Med; 2021 Jun; 23(6):e3325. PubMed ID: 33619796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-26a-5p Inhibit Gastric Cancer Cell Proliferation and Invasion Through Mediated Wnt5a.
    Li Y; Wang P; Wu LL; Yan J; Pang XY; Liu SJ
    Onco Targets Ther; 2020; 13():2537-2550. PubMed ID: 32273724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-26a-5p alleviates CFA-induced chronic inflammatory hyperalgesia through Wnt5a/CaMKII/NFAT signaling in mice.
    Lu Y; Liu M; Guo X; Wang P; Zeng F; Wang H; Tang J; Qin Z; Tao T
    CNS Neurosci Ther; 2023 May; 29(5):1254-1271. PubMed ID: 36756710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Interference of FGFR3 Impedes Invasion of Upper Tract Urothelial Carcinoma Cells by Alleviating RAS/MAPK Signal Activity.
    Huang GK; Huang CC; Kang CH; Cheng YT; Tsai PC; Kao YH; Chung YH
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-140-5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β-catenin and NF-κB cascades.
    Zhao G; Yin Y; Zhao B
    J Cell Physiol; 2020 Mar; 235(3):2161-2170. PubMed ID: 31385607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of miR-26a-5p on the Wnt/Ca(2+) Pathway and Osteogenic Differentiation of Mouse Adipose-Derived Mesenchymal Stem Cells.
    Li S; Hu C; Li J; Liu L; Jing W; Tang W; Tian W; Long J
    Calcif Tissue Int; 2016 Aug; 99(2):174-86. PubMed ID: 27040676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-26a inhibits prostate cancer progression by repression of Wnt5a.
    Zhao S; Ye X; Xiao L; Lian X; Feng Y; Li F; Li L
    Tumour Biol; 2014 Oct; 35(10):9725-33. PubMed ID: 24972966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC.
    Chang L; Li K; Guo T
    Clin Transl Oncol; 2017 Jun; 19(6):695-703. PubMed ID: 27864783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma.
    Zeng A; Yin J; Li Y; Li R; Wang Z; Zhou X; Jin X; Shen F; Yan W; You Y
    Cell Death Dis; 2018 Mar; 9(3):394. PubMed ID: 29531296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00657/miR-26a-5p/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2/p53/Bcl2/Bax pathway.
    Zhang XM; Wang J; Liu ZL; Liu H; Cheng YF; Wang T
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.